Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5329-5333, October 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gailani, D.
Right arrow Articles by Macfarlane, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gailani, D.
Right arrow Articles by Macfarlane, D. E.

Absence of Phorbol Ester-induced Down-Regulation of myc Protein in the Phorbol Ester-tolerant Mutant of HL-60 Promyelocytes1

David Gailani2,3, Frank J. Cadwell2, Peter S. O'Donnell, Robert A. Hromas2,4 and Donald E. Macfarlane5

Department of Internal Medicine, Iowa City Veterans Administration Medical Center and University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242

The human promyelocytic leukemia cell line HL-60 has an amplified number of copies of the protooncogene c-myc. It is induced to differentiate by exposure to the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA). We have developed a mutant phorbol ester-tolerant (PET) line of HL-60 which undergoes a transient growth arrest but does not differentiate when exposed to TPA (Macfarlane et al., Br. J. Haematol., 68: 291–302, 1988). The defect is not due to a general failure of TPA-induced phosphorylation. In this paper, we show that exposing phorbol estersensitive (S) HL-60 cells to TPA caused the disappearance of the c-myc protein antigen (detected on Western blots) in 4 h, whereas TPA had no effect on the c-myc protein content of PET cells. Dimethyl sulfoxide caused the rapid disappearance of the myc antigen in both cells. PET cells had slightly more copies of the c-myc gene detected on Southern blots than S cells. c-myc mRNA was equally unstable in both cells, as determined by Northern blots following actinomycin D. TPA induced the down-regulation of c-myc mRNA in S cells to a greater extent than in PET cells. Dimethyl sulfoxide caused a rapid down-regulation of c-myc mRNA in both cell lines. This shows that PET cells have a defect in the mechanism by which protein kinase C regulates c-myc transcription. Our results provide further evidence that reduction in c-myc expression is necessary for differentiation to occur in HL-60 cells.

1 This work was supported by a Merit Review Grant from the Veterans Administration.

2 Recipients of NIH Training Grant HL 07344.

3 Present address: Washington University School of Medicine, Barnard Cancer Center, St. Louis, MO 63110.

4 Present address: University of Washington School of Medicine, Division of Hematology-Oncology, Seattle, WA 98105.

5 To whom requests for reprints should be addressed, at Dept. of Internal Medicine, Division of Hematology-Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242.

Received 11/ 2/88. Revised 6/ 5/89. Accepted 6/29/89.




This article has been cited by other articles:


Home page
Cell Growth Differ.Home page
A. Lerga, P. Crespo, M. Berciano, M. D. Delgado, M. Cañelles, C. Calés, C. Richard, E. Ceballos, P. Gutierrez, N. Ajenjo, et al.
Regulation of c-Myc and Max in Megakaryocytic and Monocytic-Macrophagic Differentiation of K562 Cells Induced by Protein Kinase C Modifiers: c-Myc Is Down-Regulated but Does Not Inhibit Differentiation
Cell Growth Differ., September 1, 1999; 10(9): 639 - 654.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.